These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 22127713)

  • 1. A novel mutation of IL1RN in the deficiency of interleukin-1 receptor antagonist syndrome: description of two unrelated cases from Brazil.
    Jesus AA; Osman M; Silva CA; Kim PW; Pham TH; Gadina M; Yang B; Bertola DR; Carneiro-Sampaio M; Ferguson PJ; Renshaw BR; Schooley K; Brown M; Al-Dosari A; Al-Alami J; Sims JE; Goldbach-Mansky R; El-Shanti H
    Arthritis Rheum; 2011 Dec; 63(12):4007-17. PubMed ID: 22127713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency of Interleukin-1 Receptor Antagonist (DIRA): Report of the First Indian Patient and a Novel Deletion Affecting IL1RN.
    Mendonca LO; Malle L; Donovan FX; Chandrasekharappa SC; Montealegre Sanchez GA; Garg M; Tedgard U; Castells M; Saini SS; Dutta S; Goldbach-Mansky R; Suri D; Jesus AA
    J Clin Immunol; 2017 Jul; 37(5):445-451. PubMed ID: 28503715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case report of a novel compound heterozygous mutation in a Brazilian patient with deficiency of Interleukin-1 receptor antagonist (DIRA).
    Mendonça LO; Grossi A; Caroli F; de Oliveira RA; Kalil J; Castro FFM; Pontillo A; Ceccherini I; Barros MAMT; Gattorno M
    Pediatr Rheumatol Online J; 2020 Aug; 18(1):67. PubMed ID: 32819369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mutation of interleukin-1 receptor antagonist (IL1RN) in a DIRA patient from Turkey: Diagnosis and treatment.
    Sözeri B; Gerçeker-Türk B; Yıldız-Atıkan B; Mir S; Berdeli A
    Turk J Pediatr; 2018; 60(5):588-592. PubMed ID: 30968643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Majeed Syndrome-Causing LPIN2 Mutations Link Bone Inflammation to Inflammatory M2 Macrophages and Accelerated Osteoclastogenesis.
    Bhuyan F; de Jesus AA; Mitchell J; Leikina E; VanTries R; Herzog R; Onel KB; Oler A; Montealegre Sanchez GA; Johnson KA; Bichell L; Marrero B; De Castro LF; Huang Y; Calvo KR; Collins MT; Ganesan S; Chernomordik LV; Ferguson PJ; Goldbach-Mansky R
    Arthritis Rheumatol; 2021 Jun; 73(6):1021-1032. PubMed ID: 33314777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation screening of the IL-1 receptor antagonist gene in chronic non-bacterial osteomyelitis of childhood and adolescence.
    Beck C; Girschick HJ; Morbach H; Schwarz T; Yimam T; Frenkel J; van Gijn ME
    Clin Exp Rheumatol; 2011; 29(6):1040-3. PubMed ID: 22032624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case report: Novel compound heterozygous
    Urbaneja E; Bonet N; Solis-Moruno M; Mensa-Vilaro A; de Landazuri IO; Tormo M; Lara R; Plaza S; Fabregat V; Yagüe J; Casals F; Arostegui JI
    Front Immunol; 2024; 15():1381447. PubMed ID: 38646532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist.
    Aksentijevich I; Masters SL; Ferguson PJ; Dancey P; Frenkel J; van Royen-Kerkhoff A; Laxer R; Tedgård U; Cowen EW; Pham TH; Booty M; Estes JD; Sandler NG; Plass N; Stone DL; Turner ML; Hill S; Butman JA; Schneider R; Babyn P; El-Shanti HI; Pope E; Barron K; Bing X; Laurence A; Lee CC; Chapelle D; Clarke GI; Ohson K; Nicholson M; Gadina M; Yang B; Korman BD; Gregersen PK; van Hagen PM; Hak AE; Huizing M; Rahman P; Douek DC; Remmers EF; Kastner DL; Goldbach-Mansky R
    N Engl J Med; 2009 Jun; 360(23):2426-37. PubMed ID: 19494218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New variant in the IL1RN-gene (DIRA) associated with late-onset, CRMO-like presentation.
    Kuemmerle-Deschner JB; Welzel T; Hoertnagel K; Tsiflikas I; Hospach A; Liu X; Schlipf S; Hansmann S; Samba SD; Griesinger A; Benseler SM; Weber AN
    Rheumatology (Oxford); 2020 Nov; 59(11):3259-3263. PubMed ID: 32259833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-1 blockade in autoinflammatory syndromes.
    Jesus AA; Goldbach-Mansky R
    Annu Rev Med; 2014; 65():223-44. PubMed ID: 24422572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homozygous IL1RN Mutation in Siblings with Deficiency of Interleukin-1 Receptor Antagonist (DIRA).
    Ziaee V; Youssefian L; Faghankhani M; Jazayeri A; Saeidian AH; Vahidnezhad H; Uitto J
    J Clin Immunol; 2020 May; 40(4):637-642. PubMed ID: 32170523
    [No Abstract]   [Full Text] [Related]  

  • 12. Interleukin 1 receptor antagonist deficiency presenting as infantile pustulosis mimicking infantile pustular psoriasis.
    Minkis K; Aksentijevich I; Goldbach-Mansky R; Magro C; Scott R; Davis JG; Sardana N; Herzog R
    Arch Dermatol; 2012 Jun; 148(6):747-52. PubMed ID: 22431714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The first reported case of compound heterozygous IL1RN mutations causing deficiency of the interleukin-1 receptor antagonist.
    Stenerson M; Dufendach K; Aksentijevich I; Brady J; Austin J; Reed AM
    Arthritis Rheum; 2011 Dec; 63(12):4018-22. PubMed ID: 21792839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-1 receptor antagonist deficiency with a novel mutation; late onset and successful treatment with canakinumab: a case report.
    Ulusoy E; Karaca NE; El-Shanti H; Kilicoglu E; Aksu G; Kutukculer N
    J Med Case Rep; 2015 Jun; 9():145. PubMed ID: 26100510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monogenic autoinflammatory syndromes at a dermatological level.
    Rigante D; Cantarini L
    Arch Dermatol Res; 2011 Aug; 303(6):375-80. PubMed ID: 21340744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoinflammatory bone disorders: update on immunologic abnormalities and clues about possible triggers.
    Sharma M; Ferguson PJ
    Curr Opin Rheumatol; 2013 Sep; 25(5):658-64. PubMed ID: 23917160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro analysis of the functional effects of an NLRP3 G809S variant with the co-existence of MEFV haplotype variants in atypical autoinflammatory syndrome.
    Kubota K; Ohnishi H; Teramoto T; Matsui E; Murase K; Kanoh H; Kato Z; Kaneko H; Seishima M; Kondo N
    J Clin Immunol; 2013 Feb; 33(2):325-34. PubMed ID: 23015306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic recurrent multifocal osteomyelitis and deficiency of interleukin-1-receptor antagonist.
    Sakran W; Shalev SA; Sakran W; Shalev SA; El-Shanti H; Uziel Y; Uziel Y
    Pediatr Infect Dis J; 2013 Jan; 32(1):94. PubMed ID: 23241992
    [No Abstract]   [Full Text] [Related]  

  • 19. Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome).
    Ferguson PJ; Chen S; Tayeh MK; Ochoa L; Leal SM; Pelet A; Munnich A; Lyonnet S; Majeed HA; El-Shanti H
    J Med Genet; 2005 Jul; 42(7):551-7. PubMed ID: 15994876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases.
    Aksentijevich I; Nowak M; Mallah M; Chae JJ; Watford WT; Hofmann SR; Stein L; Russo R; Goldsmith D; Dent P; Rosenberg HF; Austin F; Remmers EF; Balow JE; Rosenzweig S; Komarow H; Shoham NG; Wood G; Jones J; Mangra N; Carrero H; Adams BS; Moore TL; Schikler K; Hoffman H; Lovell DJ; Lipnick R; Barron K; O'Shea JJ; Kastner DL; Goldbach-Mansky R
    Arthritis Rheum; 2002 Dec; 46(12):3340-8. PubMed ID: 12483741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.